Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

This program will seek to improve access to biomarker testing for patients and address the challenges community cancer programs experience when translating rapidly changing testing and treatment recommendations into clinical practice.
This program explores current barriers in care coordination and therapy options for patients who are not eligible for transplant, as well as highlights strategies and best practice guidelines to improve outcomes for patients with acute myeloid leukemia.
ACCC would like to recognize the advisory committee for the Personalizing Care for Patients of All Backgrounds project.
ACCC would like to acknowledge our committee members for CLL projects.
ACCC interviewed six members of the multidisciplinary cancer care team—including a physician, social worker, nurse, and pharmacist to discuss how their organizations are handling the challenge of treating patients with CLL during this pandemic.
Managing chronic lymphocytic leukemia (CLL) can be challenging, even under normal circumstances. But in this unprecedented era of COVID-19, the challenges have multiplied.
ACCC offers a portfolio of practical resources for multidisciplinary care teams to explore and consider implementing.
The following heat maps display chronic lymphocytic leukemia (CLL) incidence rates by state and metropolitan area and below them, institutions with specialization for treating CLL.
ACCC will develop a provider survey to identify current practice patterns regarding treatment selection, guideline-based management of adverse events, care coordination within the care team, patient education, prior authorization, and barriers to patients
Use of digital tools to collect PROs and monitor symptoms can improve the identification and treatment of adverse events, leading to improvements in patient safety, quality of life, and clinical outcomes.
Our Supporters This project is sponsored by AstraZeneca and Jazz Pharmaceuticals.
NCCS and ACCC hope to build on the increasing demand for patient involvement in all aspects of healthcare and to empower patients and patient advocates to engage with their healthcare providers to improve cancer survivorship care at the local level.
Expanding Access to Clinical Trials Pilot Project (Phase I), will gather important information about the current landscape of clinical research activity and the readiness of community-based cancer programs and practices to host cancer trials.
Our Partner Our Sponsor This project is supported by Genentech.
Our Partner Our Supporters This project is made possible by support from: Amgen, Genentech and Seagen
Case Studies in IO: A Closer Look at Care Delivery Target Audience This initiative aims to provide guidance for oncologists; oncology nurse practitioners, physician assistants, nurses, and pharmacists; patient navigators, social workers, and other healthcare professionals who are involved in the care of patients with cancer in the community setting, on the practical issues related to the optimal integration …
Our Partner Our Supporter Supported by a grant from Pfizer, Inc.
Our Supporters This project is made possible by support from AstraZeneca and Daiichi-Sankyo.
ASCO® DIRECT Highlights 2019: Melanoma & Skin Cancers Release Date: August 30, 2019 Expiration Date: August 30, 2020 Estimated time to complete: 45 minutes This educational activity is jointly provided by AXIS Medical Education and the Association of Community Cancer Centers (ACCC). This activity is supported in part by educational grants from Astellas and Seattle Genetics, Amgen, Celgene …
With the assistance of its Advisory Committee and Partner Organizations, ACCC has developed a curated resource library that incorporates publications, webinars, tools, and other resources that can help care team members with the safe dispensing of multiple myeloma therapies. Pharmacy Dispensing Resources Sample Calendar: With the numerous therapies available to treat multiple myeloma, this sample …